Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Documenti analoghi

• Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
  di: Gillies, R, et al.
  Pubblicazione: (2012)
• Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
  di: Gillies, R, et al.
  Pubblicazione: (2012)
• XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
  di: Hatch, S, et al.
  Pubblicazione: (2014)
• Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
  di: Graf, Nora, et al.
  Pubblicazione: (2012)
• Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
  di: MacGregor, T, et al.
  Pubblicazione: (2018)